# Revier Therapeutics launches with €6 million seed round for cardiometabolic pipeline

_Published Friday, August 28, 2026 at 8:06 AM EDT · Capital · Latest · Tier 2 — Notable_

![Revier Therapeutics launches with €6 million seed round for cardiometabolic pipeline — Primary](https://www.eu-startups.com/wp-content/uploads/2026/08/Untitled-design-2026-08-28T162759.857.jpg)

Heidelberg-based Revier Therapeutics has launched and closed a €6 million seed financing round led by KHAN Technology Transfer Fund II, with participation from High-Tech Gründerfonds, VORNvc and private investors. Revier says it is developing orally available small molecules intended to selectively target class IIa HDACs for heart failure with preserved ejection fraction and atherosclerotic cardiovascular disease. The company plans to use the capital for its preclinical pipeline and to build operational, scientific and clinical functions.

## Sources

- [EU-Startups](https://www.eu-startups.com/2026/08/heidelberg-based-revier-therapeutics-launches-with-e6-million-to-develop-cardiometabolic-therapies/)

---
Canonical: https://techandbusiness.org/newswire/7ies3lavndBFeAUJZ-MBks
Published: 2026-08-28T12:06:54.099Z
Story chronology: 2026-08-28T11:00:30.000Z
Retrieved: 2026-10-12T16:44:42.357Z
Publisher: Tech & Business (techandbusiness.org)